Abstract
Biomarkers seem to play an important role in understanding various diseases’ nature, course and management, including respiratory ones. Yet, discovering verifiable and validated ones, that are useful in pulmonology, is challenging and constant. A special body specimen that has been characterized as a matrix of biomarkers, is the exhaled breath condensate (EBC). It is a fluid resulting from freezing the exhaled air. Water is its main constituent. The rest is a rich mix of water-soluble volatile compounds and aerosol droplets of airway lining fluid. The droplets carry non-volatile organic compounds. Their concentration is very small and the techniques applied to measure it are very accurate and sensitive. The content of the exhaled breath condensate reflects important processes taking place in the lungs, such as inflammation and oxidative stress, which are the basis of respiratory diseases’ pathophysiology. It seems that it has a role in diagnosis, monitoring, stratification and therapy of respiratory diseases, including COVID19. This paper presents information on exhaled breath condensate and highlights its importance as a potential source of biomarkers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bake, B., Larsson, P., Ljungkvist, G., Ljungström, E., Olin, A.-C.: Exhaled particles and small airways. Respir. Res. 20(1), 8 (2019). https://doi.org/10.1186/s12931-019-0970-9
Barberis, E., et al.: Metabolomics diagnosis of COVID-19 from exhaled breath condensate. Metabolites 11, 847 (2021). https://doi.org/10.3390/metabo11120847
Califf, R.M.: Biomarker definitions and their application. Exp. Biol. Med. 243, 213–221 (2018). https://doi.org/10.1177/1535370217750088
Campanella, A., De Summa, S., Tommasi, S.: Exhaled breath condensate biomarkers for lung cancer. J. Breath Res. 13(4), 044002 (2019). https://doi.org/10.1088/1752-7163/ab2f9f
Chen, T., Liu, T., Li, T., Zhao, H., Chen, Q.: Exhaled breath analysis in disease detection. Clin. Chim. Acta 515, 61–72 (2021). https://doi.org/10.1016/j.cca.2020.12.036
Davis, M.D., Montpetit, A.J.: Exhaled breath condensate. An update. Immunol. Allergy Clin. North Am. 38, 667–678 (2018). https://doi.org/10.1016/j.iac.2018.06.002
Davis, M.D., Fowler, S.J., Montpetit, A.J.: Exhaled breath testing – A tool for the clinical and researcher. Paediatr. Respir. Rev. 29, 37–41 (2019). https://doi.org/10.1016/j.prrv.2018.05.002
De Rose, V., Molloy, K., Gohy, S., Pilette, C., Greene, C.M.: Airway epithelium dysfunction in cystic fibrosis and COPD. Mediators Inflamm. 2018, 1309746 (2018). https://doi.org/10.1155/2018/1309746
Finamore, P., Scarlata, S., Cardaci, V., Incalzi, R.A.: Exhaled breath analysis in obstructive sleep apnea syndrome: a review of the literature. Medicina (Kaunas) 55(9), 538 (2019). https://doi.org/10.3390/medicina55090538
Ghio, A.J., Madden, M.C., Esther, C.R.: Transition and post-transition metals in exhaled breath condensate. J. Breath Res. 12(2), 027112 (2018). https://doi.org/10.1088/1752-7163/aaa214
Giovannini, G., Haick, H., Garoli, D.: Detecting COVID-19 from breath: a game changer for a big challenge. ACS Sensors 6, 1408–1417 (2021). https://doi.org/10.1021/acssensors.1c00312
Hatami, H., Ghaffari, N., Ghaffari, J., Rafatpanah, H.: Role of cytokines and chemokines in the outcome of children with severe asthma: narrative review. J. Pediatr. Rev. 7(1), 17–28 (2019). https://doi.org/10.32598/jpr.7.1.17
Hayes, S.A., et al.: Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. J. Breath Res. 10(3), 034001 (2016). https://doi.org/10.1088/1752-7155/10/3/034001
Horváth, I., et al.: A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur. Respir. J. 49, 1600965 (2017). https://doi.org/10.1183/13993003.00965-2016
Kazeminasab, S., Emamalizadeh, B., Jouyban, A., Shoja, M.M., Khoubnasabjafari, M.: Macromolecular biomarkers of chronic obstructive pulmonary disease in exhaled breath condensate. Biomark. Med. 14(11), 1047–1063 (2020). https://doi.org/10.2217/bmm-2020-0121
Kazeminasab, S., Emamalizadeh, B., Jouyban-Gharamaleki, V., Taghizadieh, A., Khoubnasabjafari, M., Jouyban, J.: Tips for improving the quality and quantity of the extracted DNA from exhaled breath condensate samples. Nucleos. Nucleot. Nucl. Acids 39(5), 688–698 (2020). https://doi.org/10.1080/15257770.2019.1677910
Kazeminasab, S., Emamalizadeh, B., Khoubnasabjafari, M., Jouyban, A.: Exhaled breath condensate: a non-invasive source for tracking of genetic and epigenetic alterations in lung diseases. Pharmaceut. Sci. 27(2), 149–161 (2021). https://doi.org/10.34172/PS.2020.46
Khoubnasabjafari, M., Rahimpour, E., Jouyban, A.: Exhaled breath condensate as an alternative sample for drug monitoring. Bioanalysis 10(2), 61–64 (2018). https://doi.org/10.4155/bio-2017-0205
Khoubnasabjafari, M., Jouyban-Gharamaleki, V., Ghanbari, R., Jouyban, A.: Exhaled breath condensate as a potential specimen for diagnosing COVID-19. Bioanalysis 12(17), 1195–1197 (2020). https://doi.org/10.4155/bio-2020-0083
Khoubnasabjafari, M., et al.: Breathomics: review of sample collection and analysis, data modeling and clinical applications. Crit. Rev. Anal. Chem. 1–17 (2021). https://doi.org/10.1080/10408347.2021.1889961
Konstantinidi, E.M., Lappas, A.S., Tzortzi, A.S., Behrakis, P.K.: Exhaled Breath Condensate: Technical and Diagnostic Aspects. Sci. World J. 435160 (2015). https://doi.org/10.1155/2015/435160
Kubán, P., Foret, F.: Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. Anal. Chim. Acta 805, 1–18 (2013). https://doi.org/10.1016/j.aca.2013.07.049
Lazar, Z., Horvath, I., Vestbo, J., Bikov, A.: Exhaled breath condensate in chronic obstructive pulmonary disease: methodological challenges and clinical application. Minerva Pneumol. 57(2), 42–56 (2018). https://doi.org/10.23736/S0026-4954.18.01816-3
Maniscalco, M., Fuschillo, S., Paris, D., Cutignano, A., Sanduzzi, A., Motta, A.: Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases. Adv. Clin. Chem. 88, 121–149 (2019). https://doi.org/10.1016/bs.acc.2018.10.002
Pahwa, S., Sharma, V., Arora, V.: Biomarkers – its role in medicine. Int. J. Pharm. Sci. Res. 8(7), 2776–2788 (2017). https://doi.org/10.13040/IJPSR.0975-8232.8(7).2776-88
Peterová, E., et al.: Exhaled breath condensate: pilot study of the method and initial experience in healthy subjects. Acta Medica 61(1), 8–16 (2018). https://doi.org/10.14712/18059694.2018.17
Pérez-Sánchez, C., et al.: Clinical utility of microRNAs in exhaled breath condensate as biomarkers for lung cancer. J. Pers. Med. 11(2), 111 (2021). https://doi.org/10.3390/jpm11020111
Połomska, J., Bar, K., Sozanska, B.: Exhaled breath condensate—a non-invasive approach for diagnostic methods in asthma. J. Clin. Med. 10(12), 2697 (2021). https://doi.org/10.3390/jcm10122697
Pouwels, S.D., Burgess, J.K., Verschuuren, E., Slebos, D.J.: The cellular composition of the lung lining fluid gradually changes from bronchus to alveolus. Respir. Res. 22(1), 285 (2021). https://doi.org/10.1186/s12931-021-01882-x
Rahimpour, E., Khoubnasabjafari, M., Jouyban-Gharamaleki, V., Jouyban, A.: Non-volatile compounds in exhaled breath condensate: review of methodological aspects. Anal. Bioanal. Chem. 410(25), 6411–6440 (2018). https://doi.org/10.1007/s00216-018-1259-4
Sears, C.R., Mazzone, P.J.: Biomarkers in lung cancer. Clin. Chest Med. 41(1), 115–127 (2020). https://doi.org/10.1016/j.ccm.2019.10.004
Urs, R., Stoecklin, B., Pillow, J.J., Hartmann, B., Hall, G.L., Simpson, S.J.: Collecting exhaled breath condensate from non-ventilated preterm-born infants: a modified method. Pediatr. Res. (2021). https://doi.org/10.1038/s41390-021-01474-x
Vincent, J.L., Bogossian, E., Menozzi, M.: The future of biomarkers. Crit. Care Clin. 36(1), 177–187 (2020). https://doi.org/10.1016/j.ccc.2019.08.014
Wallace, M.A.G., Pleil, J.D.: Evolution of clinical and environmental health applications of exhaled breath research: review of methods: instrumentation for gas-phase, condensate, and aerosols. Anal. Chim. Acta 1024, 18–38 (2018). https://doi.org/10.1016/j.aca.2018.01.069
Wu, A.C., et al.: Current status and future opportunities in lung precision medicine research with a focus on biomarkers. an American Thoracic Society/National Heart, Lung, and Blood Institute research statement. Am. J. Respir. Crit. Care Med. 198(12), e116–e136 (2018). https://doi.org/10.1164/rccm.201810-1895ST
Youssef, O., Sarhadi, V.K., Armengo, G., Piirilä, P., Knuuttila, A., Knuutila, S.: Exhaled breath condensate as a source of biomarkers for lung carcinomas. A focus on genetic and epigenetic markers – a mini-review. Genes Chromosom. Cancer 55(12), 905–914 (2016). https://doi.org/10.1002/gcc.22399
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this paper
Cite this paper
Patsiris, S., Exarchos, T., Vlamos, P. (2022). Exhaled Breath Condensate Study for Biomarkers Discovery. In: Rojas, I., Valenzuela, O., Rojas, F., Herrera, L.J., Ortuño, F. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2022. Lecture Notes in Computer Science(), vol 13347. Springer, Cham. https://doi.org/10.1007/978-3-031-07802-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-031-07802-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07801-9
Online ISBN: 978-3-031-07802-6
eBook Packages: Computer ScienceComputer Science (R0)